Qomel Company Limited (9600) fair value: what the stock is really worth
As of Nov 12, 2026: fair value (intrinsic value) of Qomel Company Limited stock SAR 46.13, price SAR 34.00, upside +35.7%, quality 27 out of 100. Rating: undervalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Qomel Company Limited
9600 · SRCheap (26% below fair value), but weak company and falling price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
30‑month range 29.80 SAR – 67.50 SAR · fair‑value band 33.97 SAR – 58.29 SAR · the 34.00 SAR price screens below the 46.13 SAR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Qomel Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Qomel Company Limited operates as a healthcare company in Saudi Arabia. The company is involved in the sale of medicine and natural medicinal herbs. It also offers pharmaceutical and medical supplies services. The company was founded in 2007 and is headquartered in Riyadh, Saudi Arabia.
Stock analysis
Qomel Company Limited (9600) currently trades at 34.00 SAR, while our model-based Fair Value estimate is 46.13 SAR, implying the stock looks roughly 26% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 54.72 SAR per share, and 10 of the 14 models we run sit above the 34.00 SAR price.
Bear case: the Asset-Based group reads lowest at 4.93 SAR, and 4 of the 14 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 33.97 SAR (bear) to 58.29 SAR (bull), the price of 34.00 SAR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 27/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Qomel Company Limited reported revenue of 132M SAR in FY2025 versus 61.2M SAR in FY2021, a compound +21.2%/yr. Reported net income was 15.0M SAR in FY2025, compounding +25.0%/yr from FY2021.
Key figures
Market cap 238M SAR (≈ $63.3M) Micro · P/E ratio 22.8 · P/S ratio 2.58 · EPS (TTM) 1.49 SAR · Net margin 11.3% · Return on equity 5.6% · Return on assets (EBIT) 16.6% (5-year average) · Operating margin 8.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).
What moves the price
The share trades about 43% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 25% fair-value upside, at 36%, 9600 screens cheaper than that median.
Fair Value models
All 14 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch 9600, get fair value alerts →
Compare Qomel Company Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 52 stocks
Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Healthcare
- Valuation of the Saudi Arabia market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Al-Dawaa Medical Services Company 4163 | 37.30 SAR | 79.49 SAR | +113% | vs 9600 |
| JD Health International Inc 6618 | HK$40.66 | HK$75.64 | +86% | vs 9600 |
| Yifeng Pharmacy Chain Co 603939 | ¥25.48 | ¥40.59 | +59% | vs 9600 |
| Yixintang Pharmaceutical Group 002727 | ¥12.84 | ¥18.92 | +47% | vs 9600 |
| DaShenLin Pharmaceutical Group 603233 | ¥20.45 | ¥25.52 | +25% | vs 9600 |
| Anhui Huaren Health Pharmaceutical Co 301408 | ¥13.33 | ¥14.66 | +10% | vs 9600 |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥14.26 | ¥15.66 | +10% | vs 9600 |
| DocMorris AG DOCM | CHF 18.75 | CHF 15.17 | −19% | vs 9600 |
| ShuYu Civilian Pharmacy Corp 301017 | ¥13.72 | ¥5.91 | −57% | vs 9600 |
| Apotea AB APOTEA | kr 100.40 | kr 39.50 | −61% | vs 9600 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Qomel Company Limited (9600) overvalued or undervalued?
What is the fair value of 9600?
What is the quality score of 9600?
What is the price target for Qomel Company Limited (9600)?
What is the Qomel Company Limited stock forecast for 2026?
What is the revenue of Qomel Company Limited (9600)?
What is the intrinsic value of Qomel Company Limited (9600)?
Is Qomel Company Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 9600?
How much is Qomel Company Limited worth?
What do the bullish and bearish scenarios say about 9600?
What is the P/E ratio of 9600?
How solid is the balance sheet of Qomel Company Limited (9600)?
How far is 9600 from its 52-week high?
Which stocks are comparable to Qomel Company Limited?
Is Qomel Company Limited stock attractive at the current price?
How is the fair value of 9600 calculated?
Is it still worth investing in stocks now?
What is the share price of Qomel Company Limited (9600)?
What should I pay attention to with Qomel Company Limited right now?
Key figures of Qomel Company Limited
How large is the market capitalisation of Qomel Company Limited (9600)?
What is the P/S ratio of Qomel Company Limited (9600)?
What are the earnings per share of Qomel Company Limited (9600)?
What is the net margin of Qomel Company Limited (9600)?
What is the return on equity of Qomel Company Limited (9600)?
What is the EBIT return on assets of Qomel Company Limited (9600)?
What is the operating margin of Qomel Company Limited (9600)?
How fast is revenue growing at Qomel Company Limited (9600)?
How fast are earnings growing at Qomel Company Limited (9600)?
How much free cash flow does Qomel Company Limited (9600) generate?
How much net debt does Qomel Company Limited (9600) carry?
Watch Qomel Company Limited in the live analysis
One click puts Qomel Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.